|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beasley RP, Hwang LY, Lin CC and Chien CS:
Hepatocellular carcinoma and hepatitis B virus. A prospective study
of 22 707 men in Taiwan. Lancet. 2:1129–1133. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C,
Wang D, Sun Y, Hu G, Lang Z, et al: HBsAg and HBx knocked into the
p21 locus causes hepatocellular carcinoma in mice. Hepatology.
39:318–324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soejima K, Fang W and Rollins BJ: DNA
methyltransferase 3b contributes to oncogenic transformation
induced by SV40T antigen and activated Ras. Oncogene. 22:4723–4733.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park IY, Sohn BH, Yu E, Suh DJ, Chung YH,
Lee JH, Surzycki SJ and Lee YI: Aberrant epigenetic modifications
in hepatocarcinogenesis induced by hepatitis B virus X protein.
Gastroenterology. 132:1476–1494. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai CN, Tsai CL, Tse KP, Chang HY and
Chang YS: The Epstein-Barr virus oncogene product, latent membrane
protein 1, induces the downregulation of E-cadherin gene expression
via activation of DNA methyltransferases. Proc Natl Acad Sci USA.
99:10084–10089. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiu X, Zhang L, Lu S, Song Y, Lao Y, Hu J
and Fan H: Upregulation of DNMT1 mediated by HBx suppresses RASSF1A
expression independent of DNA methylation. Oncol Rep. 31:202–208.
2014.PubMed/NCBI
|
|
8
|
Wang Y, Lu Y, Toh ST, Sung WK, Tan P, Chow
P, Chung AY, Jooi LL and Lee CG: Lethal-7 is down-regulated by the
hepatitis B virus×protein and targets signal transducer and
activator of transcription 3. J Hepatol. 53:57–66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin L, Yin X, Hu X, Wang Q and Zheng L:
The impact of hepatitis B virus×protein and microRNAs in
hepatocellular carcinoma: A comprehensive analysis. Tumour Biol.
35:11695–11700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao
Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21
upregulation represses tumor-suppressor function of PDCD4 in
hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buyse IM, Shao G and Huang S: The
retinoblastoma protein binds to RIZ, a zinc-finger protein that
shares an epitope with the adenovirus E1A protein. Proc Natl Acad
Sci USA. 92:4467–4471. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu ZY, Wang JY, Liu HH, Ma XM, Wang CL,
Zhang XP, Tao YQ, Lu YC, Liao JC and Hu GH: Retinoblastoma
protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in
human malignant meningiomas. Oncogene. 32:1216–1222. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suzuki M, Shigematsu H, Shivapurkar N,
Reddy J, Miyajima K, Takahashi T, Gazdar AF and Frenkel EP:
Methylation of apoptosis related genes in the pathogenesis and
prognosis of prostate cancer. Cancer Lett. 242:222–230. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang W, Piao Z, Simon D, Sheu JC and Huang
S: Mapping of a minimal deleted region in human hepatocellular
carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ
(PRDM2) gene localized to the region. Genes Chromosomes Cancer.
28:269–275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tokumaru Y, Nomoto S, Jerónimo C, Henrique
R, Harden S, Trink B and Sidransky D: Biallelic inactivation of the
RIZ1 gene in human gastric cancer. Oncogene. 22:6954–6958. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oshimo Y, Oue N, Mitani Y, Nakayama H,
Kitadai Y, Yoshida K, Chayama K and Yasui W: Frequent epigenetic
inactivation of RIZ1 by promoter hypermethylation in human gastric
carcinoma. Int J Cancer. 110:212–218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Li H, Wang Y, Liu W, Zhang Q,
Zhang T, Zhang X, Han B and Zhou G: Epigenetic inactivation of the
tumor suppressor gene RIZ1 in hepatocellular carcinoma involves
both DNA methylation and histone modifications. J Hepatol.
53:889–895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nishida N, Nagasaka T, Nishimura T, Ikai
I, Boland CR and Goel A: Aberrant methylation of multiple tumor
suppressor genes in aging liver, chronic hepatitis, and
hepatocellular carcinoma. Hepatology. 47:908–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan H, Liu D, Qiu X, Qiao F, Wu Q, Su X,
Zhang F, Song Y, Zhao Z and Xie W: A functional polymorphism in the
DNA methyltransferase-3A promoter modifies the susceptibility in
gastric cancer but not in esophageal carcinoma. BMC Med. 8:122010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chappell G, Kutanzi K, Uehara T, Tryndyak
V, Hong HH, Hoenerhoff M, Beland FA, Rusyn I and Pogribny IP:
Genetic and epigenetic changes in fibrosis-associated
hepatocarcinogenesis in mice. Int J Cancer. 134:2778–2788. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hutajulu SH, Indrasari SR, Indrawati LP,
Harijadi A, Duin S, Haryana SM, Steenbergen RD, Greijer AE and
Middeldorp JM: Epigenetic markers for early detection of
nasopharyngeal carcinoma in a high risk population. Mol Cancer.
10:482011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mori N, Yoshinaga K, Tomita K, Ohwashi M,
Kondoh T, Shimura H, Wang YH, Shiseki M, Okada M and Motoji T:
Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome
and acute myeloid leukemia. Leuk Res. 35:516–521. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kong G, Zhang J, Zhang S, Shan C, Ye L and
Zhang X: Upregulated microRNA-29a by hepatitis B virus X protein
enhances hepatoma cell migration by targeting PTEN in cell culture
model. PLoS One. 6:e195182011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu
G, Zhao R, Huang H, Wang X, Qiao Y, et al: MiR-152 and miR-185
co-contribute to ovarian cancer cells cisplatin sensitivity by
targeting DNMT1 directly: A novel epigenetic therapy independent of
decitabine. Oncogene. 33:378–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ji W, Yang L, Yuan J, Yang L, Zhang M, Qi
D, Duan X, Xuan A, Zhang W, Lu J, et al: MicroRNA-152 targets DNA
methyltransferase 1 in NiS-transformed cells via a feedback
mechanism. Carcinogenesis. 34:446–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang J, Wang Y, Guo Y and Sun S:
Down-regulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du Y, Carling T, Fang W, Piao Z, Sheu JC
and Huang S: Hypermethylation in human cancers of the RIZ1 tumor
suppressor gene, a member of a histone/protein methyltransferase
superfamily. Cancer Res. 61:8094–8099. 2001.PubMed/NCBI
|
|
30
|
Abbondanza C, de Nigris F, De Rosa C,
Rossiello R, Puca GA and Napoli C: Silencing of YY1 downregulates
RIZ1 promoter in human osteosarcoma. Oncol Res. 17:33–41.
2008.PubMed/NCBI
|
|
31
|
Cheng HY, Gao Y and Lou G: DNA methylation
of the RIZ1 tumor suppressor gene plays an important role in the
tumorigenesis of cervical cancer. Eur J Med Res. 15:20–24. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong SW, Zhang P, Liu YM, Cui YT, Wang S,
Liang SJ, He Z, Sun P and Wang YG: Study on RIZ1 gene promoter
methylation status in human esophageal squamous cell carcinoma.
World J Gastroenterol. 18:576–582. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang C, Zhu Q, He H, Jiang L, Qiang Q, Hu
L, Hu G, Jiang Y, Ding X and Lu Y: RIZ1: A potential tumor
suppressor in glioma. BMC Cancer. 15:9902015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Varnholt H, Drebber U, Schulze F,
Wedemeyer I, Schirmacher P, Dienes HP and Odenthal M: MicroRNA gene
expression profile of hepatitis C virus-associated hepatocellular
carcinoma. Hepatology. 47:1223–1232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
